Indraprastha Medical Corporation balance sheet

As of Sep 2026

Total assets: ₹1,118cr+17.2% on Sep 2025
Shareholders' equity: ₹814cr+23.7% on Sep 2025
Total debt: ₹0.0crNo figure a year before
Cash and investments: ₹149cr+262.0% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	387	364	327	346	274
	2.8	2.8	32.5	0.5	2.5
	0.2	0.3	0.6	1.1	1.0
	211	0.0	0.0	0.0	0.0
	4.2	204	57.1	62.7	47.4
	215	204	57.1	62.7	47.4
	3.7	3.7	2.8	5.2	7.1
	605	575	420	415	332
	7.9	7.9	7.0	7.5	8.5
	142	0.0	0.0	0.0	0.0
	132	112	75.5	58.4	68.2
	6.5	4.9	61.5	61.6	52.3
	197	258	260	163	76.5
	13.9	10.9	9.3	6.5	6.8
	491	386	407	289	204
	13.2	12.3	16.6	11.2	10.9
	513	417	431	308	223
	1,118	991	852	723	555
Equity
	91.7	91.7	91.7	91.7	91.7
	723	649	505	386	288
	814	740	597	478	379
	814	740	597	478	379
Liabilities
	31.9	34.1	31.4	33.2	1.7
	31.9	34.1	31.4	33.2	1.7
	27.2	27.0	29.5	27.2	24.4
	21.6	20.4	15.4	19.7	20.0
	80.8	81.4	76.2	80.1	46.1
	130	128	123	140	98.2
	27.9	13.3	26.4	6.7	3.2
	158	141	149	146	101
	3.2	6.0	8.7	2.2	9.5
	0.0	0.0	0.0	0.6	4.4
	62.4	22.0	21.0	16.4	14.3
	223	170	179	165	130
	304	251	255	245	176
	1,118	991	852	723	555
Assets — additional as-filed lines
	1.3	10.1	1.0	0.0	0.0
Trade payables — MSME split
	6.3	4.2	3.7	—	—
	123	124	119	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

INDRAMEDCO₹318.30

Indraprastha Medical Corporation Limited

· Pharma & Health

₹ CrorePeersARTEMISMED SHALBY GKSL GPTHEALTH LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹2,918 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	274.1	345.9	327.5	364.5	386.9
+ Capital Work-in-Progress	2.5	0.5	32.5	2.8	2.8
+ Other Intangibles	1.0	1.1	0.6	0.3	0.2
+ Non-current Investments	0.0	0.0	0.0	0.0	210.9
+ Other Non-current Financial Assets	47.4	62.7	57.1	203.5	4.2
Non-current Financial Assets	47.4	62.7	57.1	203.5	215.1
+ Other Non-current Assets	7.1	5.2	2.8	3.7	3.7
Total Non-current Assets	332.1	415.3	420.5	574.8	605.1
Current Assets
+ Inventories	8.5	7.5	7.0	7.9	7.9
+ Current Investments	0.0	0.0	0.0	0.0	142.2
+ Trade Receivables	68.2	58.4	75.5	112.2	131.6
+ Cash & Cash Equivalents	52.3	61.6	61.5	4.9	6.5
+ Other Bank Balances	76.5	162.8	260.3	258.4	196.9
+ Other Current Financial Assets	6.8	6.5	9.3	10.9	13.9
Current Financial Assets	203.8	289.3	406.5	386.4	491.0
+ Other Current Assets	10.9	11.2	16.6	12.3	13.2
Total Current Assets	223.1	308.0	431.1	416.6	513.4
Total Assets	555.1	723.2	851.6	991.4	1,118.4
Equity
+ Equity Share Capital	91.7	91.7	91.7	91.7	91.7
+ Other Equity / Reserves	287.8	386.1	505.0	648.7	722.8
Equity — Owners of Parent	379.5	477.8	596.7	740.4	814.4
Total Equity	379.5	477.8	596.7	740.4	814.4
Liabilities
+ Other Non-current Financial Liab	1.7	33.2	31.4	34.1	31.9
Non-current Financial Liabilities	1.7	33.2	31.4	34.1	31.9
+ Provisions — Non-current	24.4	27.2	29.5	27.0	27.2
+ Deferred Tax Liabilities	20.0	19.7	15.4	20.4	21.6
Non-current Liabilities	46.1	80.1	76.2	81.4	80.8
+ Trade Payables	98.2	139.6	122.5	128.2	129.7
+ Other Current Financial Liab	3.2	6.7	26.4	13.3	27.9
Current Financial Liabilities	101.4	146.3	148.9	141.5	157.6
+ Provisions — Current	9.5	2.2	8.7	6.0	3.2
+ Current Tax Liabilities	4.4	0.6	0.0	0.0	0.0
+ Other Current Liabilities	14.3	16.4	21.0	22.0	62.4
Current Liabilities	129.6	165.4	178.7	169.6	223.3
Total Liabilities	175.7	245.5	254.9	251.0	304.0
Total Equity & Liabilities	555.1	723.2	851.6	991.4	1,118.4
Assets — additional as-filed lines
+ Current Tax Assets	0.0	0.0	1.0	10.1	1.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	3.7	4.2	6.3
+ Dues to Other Creditors — Current	—	—	118.9	124.0	123.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.